Proteins

LINCS ID Name HMS LINCS ID UniProt ID Alternative Names Provider Mutation Phosphlorylation State Domain Protein Description
201389 p57Kip2 201389 P49918
Cyclin-dependent kinase inhibitor 1C; Cyclin-dependent kinase inhibitor p57
201284 TNF10 201284 P50591
Tumor necrosis factor ligand superfamily member 10; TRAIL; Apo-2L
 R&D System
201321 TNF10 201321 P50591
Tumor necrosis factor ligand superfamily member 10; TRAIL; Apo-2L
 Sigma Recombinant human TRAIL is a 168 amino acid polypeptide (19.6 kDa), consisting of the TNF homologous portion of the extracellular domain of the full length TRAIL/Apo2L protein,1 expressed in E. coli. 1. Wiley, S.R. et al., Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3, 673-682 (1995). [source: Sigma Aldrich]
200080 CDK7 200080 P50613
Cyclin-dependent kinase 7; cell division protein kinase 7; CAK1; CDK7; CDKN7; MO15; p39MO15; STK1
 KINOMEscan Wild Type; Full length
200663 CDK7 200663 P50613
Cyclin-dependent kinase 7; cell division protein kinase 7; CAK1; CDK7; CDKN7; MO15; p39MO15; STK1
 KiNativ
200579 CDK7 200579 P50613
Cyclin-dependent kinase 7; cell division protein kinase 7; CAK1; CDK7; CDKN7; MO15; p39MO15; STK1
200082 CDK9 200082 P50750
Cyclin-dependent kinase 9; cell division protein kinase 9; C-2k; CDC2L4; CDK9; CTK1; PITALRE; TAK
 KINOMEscan Wild Type; Full length
200664 CDK9 200664 P50750
Cyclin-dependent kinase 9; cell division protein kinase 9; C-2k; CDC2L4; CDK9; CTK1; PITALRE; TAK
 KiNativ
200580 CDK9 200580 P50750
Cyclin-dependent kinase 9; cell division protein kinase 9; C-2k; CDC2L4; CDK9; CTK1; PITALRE; TAK
200049 BLK 200049 P51451
Tyrosine-protein kinase BLK; B lymphoid tyrosine kinase; BLK; MGC10442
 KINOMEscan Wild Type; Partial length
201163 BLK 201163 P51451
Tyrosine-protein kinase BLK; B lymphoid tyrosine kinase; BLK; MGC10442
 KiNativ
201164 BLK 201164 P51451
Tyrosine-protein kinase BLK; B lymphoid tyrosine kinase; BLK; MGC10442
 KiNativ
200700 IRAK1 200700 P51617
Interleukin-1 receptor-associated kinase 1
 KiNativ
200199 IRAK1 200199 P51617
Interleukin-1 receptor-associated kinase 1
 KINOMEscan Wild Type; Partial length
200596 IRAK1 200596 P51617
Interleukin-1 receptor-associated kinase 1
201008 RSK2 (Domain 1) 201008 P51812
Ribosomal protein S6 kinase alpha 3; KS6A3; S6K-alpha-3; p90-RSK 3; MAPKAPK-1b; pp90RSK2
 KiNativ domain1
200475 RSK2(Kin.Dom.2-C-terminal) 200475 P51812
Ribosomal protein S6 kinase alpha 3; KS6A3; S6K-alpha-3; p90-RSK 3; MAPKAPK-1b; pp90RSK2
 KINOMEscan Kin.Dom.2-C-terminal
201262 RSK2 domain1 201262 P51812
Ribosomal protein S6 kinase alpha 3
 KiNativ domain1
200401 RSK2(Kin.Dom.1-N-terminal) 200401 P51812
Ribosomal protein S6 kinase alpha 3; KS6A3; S6K-alpha-3; p90-RSK 3; MAPKAPK-1b; pp90RSK2
 KINOMEscan Kin.Dom.1-N-terminal) Wild Type; Partial length
200822 RSK2_domain2 200822 P51812
Ribosomal protein S6 kinase alpha 3; KS6A3; S6K-alpha-3; p90-RSK 3; MAPKAPK-1b; pp90RSK2
 KiNativ domain2
200388 RPS6KA3(Kin.Dom.1) 200388 P51812
Ribosomal protein S6 kinase, 90kDa, polypeptide 3; CLS; HU-3; ISPK-1; MAPKAPK1B; MRX19; p90-RSK2; pp90RSK2; RPS6KA3; RSK; RSK2; S6K-alpha3
 KINOMEscan Kin.Dom.1
200820 RSK2_domain1 200820 P51812
Ribosomal protein S6 kinase alpha 3; KS6A3; S6K-alpha-3; p90-RSK 3; MAPKAPK-1b; pp90RSK2
 KiNativ domain1
201383 S6K-alpha-3 (pS386) 201383 P51812 pS386
201376 S6K-alpha-3 (pT356) 201376 P51812 pT356
200622 S6K-alpha-3 200622 P51812
Ribosomal protein S6 kinase alpha-3; 90 kDa ribosomal protein S6 kinase 3; p90-RSK 3; p90RSK3; Insulin-stimulated protein kinase 1; ISPK-1; MAP kinase-activated protein kinase 1b; MAPK-activated protein kinase 1b; MAPKAP kinase 1b; MAPKAPK-1b; Ribosomal S6 kinase 2; RSK-2; pp90RSK2